# Amn Healthcare Services (AMN) — Earnings

AMN · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/amn/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.77 |
| EPS estimate | $0.19 |
| EPS surprise | +307.84% |
| Revenue surprise | +7.13% |
| Revenue | $673.2M |
| Revenue estimate | $628.4M |
| Reported | Aug 6, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1142750/000162828026054507/amn-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/03d92628-2e41-28ed-69e0-7955ac392550.html) |

AMN Healthcare reported Q2 2026 results on August 6, 2026. Earnings per share were $0.77, far above the $0.19 estimate, a beat of 307.84%. Revenue of $673.2 million topped the $628.4 million consensus by about 7%. Compared with Q2 2025, EPS rose about 157% from $0.30, while revenue grew about 2% from $658.2 million.

The longer record shows a steep decline followed by an uneven 2026. Annual EPS fell from $11.85 in 2022 to $8.16 in 2023, $3.31 in 2024 and $1.36 in 2025. Quarterly revenue peaked in the table at $1.6 billion in Q1 2022 and settled between about $630 million and $750 million through 2025. Q1 2026 stands out at $2.10 per share on $1.4 billion of revenue, roughly double the quarters on either side. AMN beat the EPS estimate in 19 of the last 20 quarters. The only miss was Q4 2025, at 17.82% below.

AMN has reported third-quarter results between November 2 and November 7 in each of the past five years. That points to early November 2026 for the Q3 report. It will show whether EPS stays above last year's levels and whether revenue holds near the Q2 figure.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 6, 2026 | $0.19 | $0.77 | 307.84% | $628.4M | $673.2M |
| Q1 2026 | May 7, 2026 | $1.62 | $2.10 | 29.91% | $1.2B | $1.4B |
| Q4 2025 | Feb 19, 2026 | $0.27 | $0.22 | -17.82% | $723.7M | $748.2M |
| Q3 2025 | Nov 6, 2025 | $0.20 | $0.39 | 95.00% | $618.1M | $634.5M |
| Q2 2025 | Aug 7, 2025 | $0.18 | $0.30 | 64.65% | $652.1M | $658.2M |
| Q1 2025 | May 8, 2025 | $0.21 | $0.45 | 118.66% | $670.0M | $689.5M |
| Q4 2024 | Feb 20, 2025 | $0.49 | $0.75 | 53.66% | $694.4M | $734.7M |
| Q3 2024 | Nov 7, 2024 | $0.57 | $0.61 | 6.29% | $671.5M | $687.5M |
| Q2 2024 | Aug 8, 2024 | $0.78 | $0.98 | 26.08% | $740.4M | $740.7M |
| Q1 2024 | May 9, 2024 | $0.96 | $0.97 | 1.35% | $816.5M | $820.9M |
| Q4 2023 | Feb 15, 2024 | $1.25 | $1.32 | 5.38% | $803.1M | $818.3M |
| Q3 2023 | Nov 2, 2023 | $1.63 | $1.97 | 20.52% | $851.2M | $853.5M |
| Q2 2023 | Aug 3, 2023 | $2.14 | $2.38 | 10.97% | $988.3M | $991.3M |
| Q1 2023 | May 4, 2023 | $2.36 | $2.49 | 5.57% | $1.1B | $1.1B |
| Q4 2022 | Feb 16, 2023 | $2.14 | $2.48 | 15.83% | $1.1B | $1.1B |
| Q3 2022 | Nov 3, 2022 | $2.37 | $2.57 | 8.49% | $1.1B | $1.1B |
| Q2 2022 | Aug 4, 2022 | $2.97 | $3.31 | 11.57% | $1.4B | $1.4B |
| Q1 2022 | May 5, 2022 | $3.20 | $3.49 | 9.05% | $1.5B | $1.6B |
| Q4 2021 | Feb 17, 2022 | $2.66 | $2.95 | 11.05% | $1.3B | $1.4B |
| Q3 2021 | Nov 4, 2021 | $1.30 | $1.73 | 32.74% | $783.1M | $877.8M |

## Frequently Asked Questions

### When did Amn Healthcare Services (AMN) last report earnings?

Amn Healthcare Services last reported on Aug 6, 2026, covering fiscal Q2 2026.

### Did AMN beat earnings estimates?

Yes. Amn Healthcare Services reported EPS of $0.77 for Q2 2026 against a $0.19 estimate — a 307.84% beat.

### How much revenue did AMN report last quarter?

Amn Healthcare Services reported $673.2M in revenue for Q2 2026, against a consensus estimate of $628.4M.

## Similar Stocks

- [MEDP](https://www.lighthorse.io/tickers/medp) — Medpace Holdings, Inc. - Common Stock
- [VEEV](https://www.lighthorse.io/tickers/veev) — Veeva Systems Inc. Class A Common Stock
- [WST](https://www.lighthorse.io/tickers/wst) — West Pharmaceutical Services, Inc. Common Stock
- [EYE](https://www.lighthorse.io/tickers/eye) — National Vision Holdings, Inc. - Common Stock

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).